Pneumococcal and rotavirus vaccines to decrease pediatric hospitalization
These reductions would be apparent within fewer than five years after the vaccines is introduced.
The goal of the study was to determine the combined effect of co-administering rotavirus vaccines and PCVs. This was part of a heightened prospective surveillance in southern Israel.
"Our findings confirm the utmost importance of co-contribution of pneumococcal and rotavirus vaccines in reduction of burden of severe diarrhea and respiratory diseases reduction, especially during winter, the season with peak hospitalization rates of young children," Dr. Ron Dagan, principal investigator and professor of pediatrics and infectious diseases at the Pediatric Infectious Disease Unit, Soroka University Medical Center, Israel, said.
Young children and infants often contract diarrheal diseases and winter respiratory illnesses because of specific bacterium, like the rotavirus and Streptococcus penumoniae (the pneumococcus). These new vaccines could decrease the impact the disease has on populations. Unfortunately, the researchers have not been able to determine whether both of the vaccines could decrease the hospital burden during the fall and winter seasons.
Further details were presented at the ASM’s 55th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC/ICC).